在药理动力学中制定和验证扩展的Sigmoid Emax模型
1Department of Mathematics, College of Natural Sciences and Institute of Mathematical Sciences, Pusan National University, Busan, 46241, Republic of Korea. maticax@pusan.ac.kr.
Pharmaceutical research
|August 14, 2024
概括
扩展的Emax (eEmax) 模型通过从一个数据集生成多个曲线来改进药物度-反应分析,提高数据的准确性和利用率. 这种灵活的方法减少了药理动力学-药理动力学 (PKPD) 建模中的验证错误.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药理动力学 药理动力学
- 药理动力学是什么 药理动力学
背景情况:
- 药物度-反应曲线 (DRC) 对于评估药物效应至关重要.
- 标准的Emax模型虽然有用,但在准确性和数据利用方面存在局限性,因为它依赖于有效药物度 (EC50).
- 由于Emax模型无法从单个数据集中生成多个DRC,因此对不完整的数据分析产生了担忧.
研究的目的:
- 引入一个扩展的Emax (eEmax) 模型,以解决传统Emax模型的局限性.
- 开发一种方法,提高药物度-反应分析的准确性和灵活性.
- 为了实现从单一数据集生成多个DRC,以便进行更全面的分析.
主要方法:
- 扩展的Emax (eEmax) 模型的制定.
- 该eEmax模型通过改变有效药物度 (EC50) 来估计多个DRC,同时保持最大效应 (Emax) 不变.
- 使用来自单一数据集的各种估计EC50值.
主要成果:
- eEmax模型在捕捉度-反应关系方面表现出更高的灵活性和准确性,包括非细分形模式.
- 跨多种药物反应数据集和药理动力学 (PKPD) 框架的验证证实了eEmax模型的卓越性能.
- 该模型有效地处理度-反应数据,比标准Emax模型更准确.
结论:
- eEmax模型为药物度-反应分析提供了一种强大而可适应的方法.
- 它可以从单个数据集生成多个DRC,从而最大限度地减少验证错误.
- eEmax模型的易用性和完整数据集利用能力使其在PKPD建模和药物发现方面具有价值.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Pharmacokinetic Models: Overview
627
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
627
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
73
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
73
Model Approaches for Pharmacokinetic Data: Physiological Models
36
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
36
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241


